| Announce Date | 11/03/2025 |
| EPS Normalized Actual | $-0.05 In Line |
| EPS GAAP Actual | $-0.05 In Line |
| Revenue Actual | $0.010112B |
| Revenue Surprise | Beat by $10.112M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $-0.013667 |
| EPS GAAP Estimate | $-0.013667 |
| Revenue Estimate | $0.0555B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2028 | 0.13 | 64 | 0.10666 | 0.16116 | 3 |
| Dec 2027 | 0.51 | 16.31 | 0.41836 | 0.66034 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0 | 0.036743 | 0.010112B | -114.41% | -25.74M |
| FQ2 2025 (Jun 2025) | -0.25 | -0.25 | 0.01449B | -41.26% | 14.49M |
| FQ1 2025 (Mar 2025) | -0.09 | -0.09 | 0.014018B | -65.32% | 14.02M |
| FQ4 2024 (Dec 2024) | -0.21 | -0.21 | 0.017978B | -44.94% | 17.98M |
| FQ3 2024 (Sep 2024) | -0.1 | -0.1 | 0.021681B | 100% | 21.68M |
| FQ1 2020 (Mar 2020) | -0.26 | -0.26 | 0.00118B | 100% | 1.18M |
| FQ2 2020 (Jun 2020) | -0.27 | -0.27 | 0.002516B | 100% | 2.52M |
| FQ3 2020 (Sep 2020) | -0.27 | -0.27 | 0.0035B | 100% | 3.5M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
-0.013667
Consensus Revenue Estimates
0.0555B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | -0.005797 | -- | -0.00696484 | -0.00512186 | 1 |
| FQ3 2027 (Sep 2027) | 0.02 | -- | 0.01894673 | 0.02073951 | 1 |
| FQ2 2027 (Jun 2027) | 0.01 | -- | 0.00947337 | 0.01036976 | 1 |
| FQ1 2027 (Mar 2027) | 0 | -- | 0 | 0 | 1 |
| FQ4 2026 (Oct 2026) | -0.006667 | -- | -0.00759491 | -0.00622493 | 1 |
| FQ3 2026 (Jul 2026) | -0.023333 | -- | -0.02658049 | -0.02178586 | 1 |
| FQ2 2026 (Jun 2026) | -0.007 | -3471.43 | -0.00758766 | -0.0065742 | 1 |
| FQ1 2026 (Mar 2026) | -0.013667 | -558.52 | -0.01481436 | -0.01283565 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.05B | -- | 0.04B | 0.05B | 2 |
| FQ3 2027 (Sep 2027) | 0.05B | -- | 0.05B | 0.05B | 2 |
| FQ2 2027 (Jun 2027) | 0.04B | -- | 0.04B | 0.05B | 2 |
| FQ1 2027 (Mar 2027) | 0.04B | -- | 0.04B | 0.04B | 2 |
| FQ4 2026 (Oct 2026) | 0.07B | -- | 0.06B | 0.07B | 2 |
| FQ3 2026 (Jul 2026) | 0.05B | 81.2 | 0.05B | 0.06B | 2 |
| FQ2 2026 (Jun 2026) | 0.06B | 76.57 | 0.06B | 0.07B | 2 |
| FQ1 2026 (Mar 2026) | 0.06B | 74.74 | 0.05B | 0.06B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
1
EPS # of Misses
7
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.036743 | 0 | 0.036743 | INF% |
| FQ2 2025 (Jun 2025) | -0.25 | -0.25 | 100% | |
| FQ1 2025 (Mar 2025) | -0.09 | -0.09 | 100% | |
| FQ4 2024 (Dec 2024) | -0.21 | -0.21 | 100% | |
| FQ3 2024 (Sep 2024) | -0.1 | -0.1 | 100% | |
| FQ1 2020 (Mar 2020) | -0.26 | -0.26 | 100% | |
| FQ2 2020 (Jun 2020) | -0.27 | -0.27 | 100% | |
| FQ3 2020 (Sep 2020) | -0.27 | -0.27 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0.04B | $0.01B | $-25.74M | -254.53% |
| FQ2 2025 (Jun 2025) | $0B | $0.01B | $14.49M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $0.01B | $14.02M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $0.02B | $17.98M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0.02B | $21.68M | 100% |
| FQ1 2020 (Mar 2020) | $0B | $0B | $1.18M | 100% |
| FQ2 2020 (Jun 2020) | $0B | $0B | $2.52M | 100% |
| FQ3 2020 (Sep 2020) | $0B | $0B | $3.5M | 100% |